The future of cancer resistance research is promising, with advancements in genomics, proteomics, and bioinformatics providing deeper insights into resistance mechanisms. The development of next-generation sequencing technologies and single-cell analysis is enabling a more detailed understanding of tumor heterogeneity and resistance evolution. This knowledge is crucial for developing more effective and personalized treatment strategies.
